Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-25 @ 6:59 PM
NCT ID:
NCT00910104
Population Description:
Includes subjects treated with Omegaven and subjects who served as historical controls treated with Intralipid. Four participants who were transferred to Boston Children's after starting Omegaven at another institution do not have a baseline direct bilirubin (DB). These same four subjects plus two subjects on Intralipid do not have a PN start date, so duration of PN will be unknown in these cases. Therefore, the sample size for DB will be 38+49=87 and for duration of PN 38+47=85.
Study:
NCT00910104
Study Brief:
Results Section:
NCT00910104